Last week, the Food and Drug Administration banned Red Dye No. 3 over cancer risks. Good.

Dr. Mrinal M Gounder emphasizes the complexity of breast cancer and the necessity for unique treatments for its many variants ...

The pathway allows medicine developers to work with the regulators, the NHS and health technology assessment bodies.

The FDA said manufacturers who use red three in food and ingested drugs will have until January 15, 2027 or January 18, 2028, respectively, to reformulate their products.

In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr ...

Senators had objected to the financial conflict posed by Robert F. Kennedy Jr.’s decision to retain a financial stake in ...

RFK Jr.'s confirmation hearings continue today as he appears before a second Senate committee. Follow STAT's live updates.

AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...

Among patients with advanced PIK3CA-mutated, HR-positive/HER2-negative breast cancer, Itovebi-based treatment generated positive overall survival results.

After the Red No. 3 ban, there are now eight color additives approved by the FDA. They are FD&C Blue No. 1, FD&C Blue No. 2, ...

The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...